T&D Diagnostics Headquartered in Canada with manufacturing unit in Netherlands recently updated its plans to manufacture more products in India. T&D entered into a strategic partnership with Genenest – A Noida-based Biotech company to manufacture its FIA range in India. Under this strategic partnership, Genenest
In a striking projection that underscores the country’s ongoing health sector transformation, CareEdge Ratings has reported that India’s total healthcare expenditure is expected to rise from 3.3% to 5% of its Gross Domestic Product (GDP) by the year 2030. The anticipated growth reflects a combination
Everest Group, a leading global research and consulting firm, has recognized Indegene as a front-runner in generative AI (GenAI) life sciences market adoption. In its report, 'AI-deas to Action: Operationalizing Generative AI in Life Sciences', Everest Group acknowledged Indegene’s comprehensive GenAI capabilities, including scale, breadth
Syngene International Limited today announced that Jonathan Hunt has stepped down from his role as MD & CEO as well as from the Board of Directors to pursue other opportunities in due course. Consequent to this, the Board has appointed Peter Bains as the CEO
Sun Pharmaceutical Industries Ltd. announced on Monday that it has entered into a global licensing agreement with Swiss-Italian biotech firm Philogen to commercialize the specialty anti-cancer immunotherapy, Fibromun (L19TNF). This innovative treatment is currently under investigation in registration trials for the treatment of soft tissue
The second day of the 25th Bengaluru Technology Summit (BTS 2022) organized by The Department of Electronics, IT, Bt, S&T, Government of Karnataka witnessed a flood of business visitors and experts from the IT, BT and Deeptech to the exhibition area and technology conferences. Several industry
